These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 5756259)

  • 21. [Optimization of therapy using cardiac glycosides].
    Ziesenhenn K; Behn P
    Z Gesamte Inn Med; 1978 Nov; 33(22):830-3. PubMed ID: 746673
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The use of proscillaridin A in the therapy of cardiac insufficiency in the aged].
    Castrucci D; Morini PL
    Minerva Med; 1967 Nov; 58(91):3917-21. PubMed ID: 6081708
    [No Abstract]   [Full Text] [Related]  

  • 23. Clinical and haemodynamic studies with peruvoside (Cd. 421) in congestive heart failure.
    Bhatia ML; Manchanda SS; Gupta SP; Roy SB
    Indian Heart J; 1971 Apr; 23(2):159-63. PubMed ID: 5154111
    [No Abstract]   [Full Text] [Related]  

  • 24. [Cardiac glycosides: indications, selection and dosage].
    Kuhlmann J
    Med Klin; 1982 Jan; 77(3):18-22. PubMed ID: 7057727
    [No Abstract]   [Full Text] [Related]  

  • 25. Treatment of chronic right-heart lesions. Proscillaridin for cor pulmonale and the senile heart.
    Neumann H
    Geriatrics; 1966 Jun; 21(6):180-5. PubMed ID: 5949184
    [No Abstract]   [Full Text] [Related]  

  • 26. [Introduction to clinical pharmacodynamics and pharmacokinetics of cardiac glycosides].
    Kudrin AN; Namakanov BA; Davydova ON
    Sov Med; 1981; (11):70-4. PubMed ID: 7038899
    [No Abstract]   [Full Text] [Related]  

  • 27. Pharmacological evaluation of peruvoside, a new cardiac glycoside from Thevetia neriifolia with a note on its clinical trials in patients with congestive heart failure.
    Arora RB; Sharma JN; Bhatia ML
    Indian J Exp Biol; 1967 Jan; 5(1):31-6. PubMed ID: 6036987
    [No Abstract]   [Full Text] [Related]  

  • 28. [Studies on the relationships between the glycoside dosage effect and pulse frequency behavior].
    Döring D; Wenzel V
    Z Gesamte Inn Med; 1966 Jun; 21(12):Suppl:137-8. PubMed ID: 5987624
    [No Abstract]   [Full Text] [Related]  

  • 29. [Blood level kinetics and renal clearance of H3 peruvosid].
    Kramer P; Willms B; Horenkamp J; Scheler F
    Klin Wochenschr; 1969 Nov; 47(21):1157-66. PubMed ID: 5382005
    [No Abstract]   [Full Text] [Related]  

  • 30. [Comparative studies on the uptake of cardiac glycosides by the cell].
    Hüsten J; Ruiz-Torres A
    Verh Dtsch Ges Inn Med; 1969; 75():396-9. PubMed ID: 5400163
    [No Abstract]   [Full Text] [Related]  

  • 31. The effects of reserpine and propranolol on the therapeutic and toxic effects of peruvoside in the heart-lung preparation and intact dogs.
    Arora RB; Bagchi N; Gupta OP
    Indian J Med Res; 1972 Jan; 60(1):143-52. PubMed ID: 5029118
    [No Abstract]   [Full Text] [Related]  

  • 32. [Toxic effects and pharmacokinetics of cardiac glycosides in mice with experimental radiation disease].
    Tilser I; Krupicková H; Kozák I
    Sb Ved Pr Lek Fak Karlovy Univerzity Hradci Kralove Suppl; 1981; 24(1):123-41. PubMed ID: 6975978
    [No Abstract]   [Full Text] [Related]  

  • 33. [Clinical studies on the pharmacological effects and 24-hour excretion of Sanoscill].
    Tabeau J; Bobrowski A; Kudla A; Gabryś B
    Pol Tyg Lek; 1969 Mar; 24(12):433-6. PubMed ID: 5768694
    [No Abstract]   [Full Text] [Related]  

  • 34. [Interaction of cardiac glycosides with other drugs].
    Greeff K
    Verh Dtsch Ges Herz Kreislaufforsch; 1982; 48():40-6. PubMed ID: 7187163
    [No Abstract]   [Full Text] [Related]  

  • 35. [Effect of diseases on the kinetics of cardiac glycosides and its significance for general practice].
    Gilfrich HJ
    Verh Dtsch Ges Herz Kreislaufforsch; 1982; 48():28-34. PubMed ID: 7187161
    [No Abstract]   [Full Text] [Related]  

  • 36. [Effective concentration and dosage for cardiac glycosides].
    Weiss M; Förster W
    Z Gesamte Inn Med; 1980 Jan; 35(1):1-7. PubMed ID: 6996345
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Pharmacokinetic differentiation of cardiac glycosides].
    Wirth KE
    Verh Dtsch Ges Herz Kreislaufforsch; 1982; 48():19-27. PubMed ID: 7187160
    [No Abstract]   [Full Text] [Related]  

  • 38. [Kinetics of cumulation of heart glycosides in central nervous system].
    Rietbrock N; Kuhlmann J
    Med Klin; 1977 Jul; 72(28-29):1218-9. PubMed ID: 887048
    [No Abstract]   [Full Text] [Related]  

  • 39. [A slide ruler and nomogram for calculations in cumulation kinetics of cardiac glycosides (author's transl)].
    Kratochvil L; Lustig M
    Basic Res Cardiol; 1976; 71(2):160-72. PubMed ID: 1267742
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Studies on peruvoside. 1. Early manifestations & comparative toxicity in guineapig & dog.
    Arora RB; Sundaresan PR
    Indian J Exp Biol; 1973 Jul; 11(4):295-300. PubMed ID: 4783380
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.